SCHEMBL21532575

SCHEMBL21532575

c1cncc(-c2nnc(-c3cccnc3)n2-c2ccc3c(c2)c2ccccc2n3-c2cccc(-n3c4ccccc4c4c5oc6ccccc6c5ccc43)c2)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.36
DHFR P00374 1/20 0.34
HTT P42858 1/20 0.33
ALDH1A1 P00352 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPK1 P28482 2/20 0.33
TSHR P16473 1/20 0.33
GAA P10253 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
CYP11B2 P19099 1/20 0.32
APLNR P35414 1/20 0.31
KDM4E B2RXH2 1/20 0.31
CYP1A1 P04798 1/20 0.31
CYP1A2 P05177 1/20 0.31
PRKDC P78527 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532177 0.91 ALDH1A1 (0.36) MAPTHTTALDH1A1L3MBTL1MAPK1
SCHEMBL21532284 0.88 ALDH1A1 (0.35) MAPTALDH1A1L3MBTL1MAPK1TSHR
SCHEMBL21532305 0.87 ALDH1A1 (0.34) MAPTALDH1A1L3MBTL1MAPK1TSHR
SCHEMBL21532180 0.87 ALDH1A1 (0.36) MAPTHTTALDH1A1L3MBTL1MAPK1
SCHEMBL17636670 0.85 MAPT (0.46) MAPTDHFRHTTALDH1A1L3MBTL1
SCHEMBL21532387 0.85 AVPR1A (0.36) ALDH1A1L3MBTL1MAPK1TSHRLMNA
SCHEMBL21532572 0.85 ALOX5 (0.35) ALDH1A1L3MBTL1MAPK1TSHRLMNA
SCHEMBL21532616 0.85 ALDH1A1 (0.35) ALDH1A1L3MBTL1MAPK1TSHRLMNA
SCHEMBL21532801 0.85 ALDH1A1 (0.36) MAPTHTTALDH1A1L3MBTL1MAPK1
SCHEMBL21532615 0.84 KDM4E (0.36) ALDH1A1L3MBTL1MAPK1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 MAPT 676/4885DHFR 4025/4885HTT 1097/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 MAPT 944/4885DHFR 4258/4885HTT 1934/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.